COMPANY

Glytr Therapeutics, Inc.

Keywords: cell therapy CAR-T oncology

Location: Irvine, CA · source · Oct 12, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $1M (STTR Phase II 4R42CA302415-02, extension, notice Sep 16, 2026). NIH RePORTER 4R42CA302415-02 (Sep 16, 2026)
Evidence (1 event)
- Sep 16, 2026 · NIH RePORTER 4R42CA302415-02
  Organization: GLYTR THERAPEUTICS, INC.; City/State: San Carlos, CA; Project number: 4R42CA302415-02; Activity code: R42; Fiscal year: 2026; Award notice date: 2026-09-16; FY total cost (award amount): 1002331; Administering IC: National Cancer Institute; Project title: Maximizing GlyTR pan-cancer immunotherapy by enhancing target density; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Sep 16, 2026 Grant Government grant — STTR: $1M (annual award, as published), announced Sep 16, 2026. Agency: NIH/NCI. Source: government award database. source ↗
Sep 10, 2025 Grant Government grant — STTR: $463,510 (annual award, as published), announced Sep 10, 2025. Agency: NIH/NCI. Source: government award database. source ↗
Aug 22, 2025 Grant Government grant — STTR: $1.09M (annual award, as published), announced Aug 22, 2025. Agency: NIH/NCI. Source: government award database. source ↗

Last 2 years.

Sep 16, 2026 Government grant — STTR: $1M (annual award, as published), announced Sep 16, 2026. Agency: NIH/NCI. Source: government award database. source ↗
Sep 10, 2025 Government grant — STTR: $463,510 (annual award, as published), announced Sep 10, 2025. Agency: NIH/NCI. Source: government award database. source ↗
Aug 22, 2025 Government grant — STTR: $1.09M (annual award, as published), announced Aug 22, 2025. Agency: NIH/NCI. Source: government award database. source ↗